v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid in Capital
Accumulated Deficit
Accumulated  Other Comprehensive Income
Treasury Stock Amount
Beginning balance (in shares) at Dec. 31, 2022       450,575 393,014        
Beginning balance at Dec. 31, 2022 $ 1,322,693     $ 45 $ 39 $ 6,750,055 $ (5,131,801) $ 36,488 $ (332,133)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares)       701          
Exercise of stock options 2,192         2,192      
Stock-based compensation expense 117,400         117,400      
Purchase of treasury stock (in shares)       (1,399)          
Purchase of treasury stock (27,358)               (27,358)
Restricted stock unit vesting (in shares)       11,757          
Restricted stock unit vesting 1     $ 1          
Net income (loss) (397,148)           (397,148)    
Ending balance (in shares) at Mar. 31, 2023       461,634 393,014        
Ending balance at Mar. 31, 2023 1,017,780     $ 46 $ 39 6,869,647 (5,528,949) 36,488 (359,491)
Beginning balance (in shares) at Dec. 31, 2022       450,575 393,014        
Beginning balance at Dec. 31, 2022 1,322,693     $ 45 $ 39 6,750,055 (5,131,801) 36,488 (332,133)
Increase (Decrease) in Stockholders' Equity                  
Shares issued in connection with business combinations 0                
Net income (loss) (474,418)                
Ending balance (in shares) at Jun. 30, 2023       463,257 393,014        
Ending balance at Jun. 30, 2023 1,018,491     $ 46 $ 39 6,961,454 (5,606,219) 36,488 (373,317)
Beginning balance (in shares) at Mar. 31, 2023       461,634 393,014        
Beginning balance at Mar. 31, 2023 1,017,780     $ 46 $ 39 6,869,647 (5,528,949) 36,488 (359,491)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares)       284          
Exercise of stock options 1,144         1,144      
Stock-based compensation expense 89,193         89,193      
Shares issued for exercise of warrants (in shares)       62          
Exercise of warrants 1,470         1,470      
Purchase of treasury stock (in shares)       (587)          
Purchase of treasury stock (13,826)               (13,826)
Restricted stock unit vesting (in shares)       1,864          
Restricted stock unit vesting 0                
Net income (loss) (77,270)           (77,270)    
Ending balance (in shares) at Jun. 30, 2023       463,257 393,014        
Ending balance at Jun. 30, 2023 1,018,491     $ 46 $ 39 6,961,454 (5,606,219) 36,488 (373,317)
Beginning balance (in shares) at Dec. 31, 2023   472,697 393,014 472,697 393,014        
Beginning balance at Dec. 31, 2023 840,306     $ 46 $ 39 7,149,858 (5,933,943) 36,488 (412,182)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares)       630          
Exercise of stock options 2,857         2,857      
Stock-based compensation expense 117,702         117,702      
Shares issued for exercise of warrants (in shares)       1,002          
Exercise of warrants 46,181         46,181      
Purchase of treasury stock (in shares)       (782)          
Purchase of treasury stock (33,499)               (33,499)
Restricted stock unit vesting (in shares)       2,520          
Restricted stock unit vesting 0                
Net income (loss) (142,568)           (142,568)    
Ending balance (in shares) at Mar. 31, 2024       476,067 393,014        
Ending balance at Mar. 31, 2024 830,979     $ 46 $ 39 7,316,598 (6,076,511) 36,488 (445,681)
Beginning balance (in shares) at Dec. 31, 2023   472,697 393,014 472,697 393,014        
Beginning balance at Dec. 31, 2023 $ 840,306     $ 46 $ 39 7,149,858 (5,933,943) 36,488 (412,182)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares) 5,377                
Shares issued in connection with business combinations $ 331,557                
Net income (loss) (78,746)                
Ending balance (in shares) at Jun. 30, 2024   485,426 393,014 485,426 393,014        
Ending balance at Jun. 30, 2024 1,298,429     $ 47 $ 39 7,744,638 (6,012,689) 36,488 (470,094)
Beginning balance (in shares) at Mar. 31, 2024       476,067 393,014        
Beginning balance at Mar. 31, 2024 830,979     $ 46 $ 39 7,316,598 (6,076,511) 36,488 (445,681)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares)       257          
Exercise of stock options 2,586         2,586      
Stock-based compensation expense 93,681         93,681      
Shares issued for exercise of warrants (in shares)       6          
Exercise of warrants 217         217      
Purchase of treasury stock (in shares)       (631)          
Purchase of treasury stock (24,413)               (24,413)
Restricted stock unit vesting (in shares)       1,970          
Restricted stock unit vesting 0                
Shares issued in connection with business combinations (in shares)       7,757          
Shares issued in connection with business combinations 331,557     $ 1   331,556      
Net income (loss) 63,822           63,822    
Ending balance (in shares) at Jun. 30, 2024   485,426 393,014 485,426 393,014        
Ending balance at Jun. 30, 2024 $ 1,298,429     $ 47 $ 39 $ 7,744,638 $ (6,012,689) $ 36,488 $ (470,094)